Matyskin AV, Angermeier SB, Drera SS, Prible MC, Geuther JA, Heibel MD. Actinium-225 photonuclear production in nuclear reactors using a mixed radium-226 and gadolinium-157 target.
Nucl Med Biol 2024;
136-137:108940. [PMID:
39002498 DOI:
10.1016/j.nucmedbio.2024.108940]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Revised: 06/17/2024] [Accepted: 07/02/2024] [Indexed: 07/15/2024]
Abstract
BACKGROUND
Actinium-225 is one of the most promising radionuclides for targeted alpha therapy. Its limited availability significantly restricts clinical trials and potential applications of 225Ac-based radiopharmaceuticals.
METHODS
In this work, we examine the possibility of 225Ac production from the thermal neutron flux of a nuclear reactor. For this purpose, a target consisting of 1.4 mg of 226Ra(NO3)2 (T1/2 = 1600 years) and 115.5 mg of 90 % enriched, stable 157Gd2O3 was irradiated for 48 h in the Breazeale Nuclear Reactor with an average neutron flux of 1.7·1013 cm-2·s-1. Gadolinium-157 has one of the highest thermal neutron capture cross sections of 0.25 Mb, and its neutron capture results in emission of high-energy, prompt γ-photons. Emitted γ-photons interact with 226Ra to produce 225Ra according to the 226Ra(γ, n)225Ra reaction. Gadolinium debulking and separation of undesirable, co-produced 227Ac from 225Ra was achieved in one step by using 60 g of branched DGA resin. After 225Ac ingrowth from 225Ra (T1/2 = 14.8 d), 225Ac was extracted from the 226Ra and 225Ra fraction using 5 g of bDGA resin and then eluted using 5 mM HNO3.
RESULTS
Measured activity of 225Ac showed that 6(1) kBq or 0.16(3) μCi (1σ) of 225Ra was produced at the end of bombardment from 0.9 mg of 226Ra.
CONCLUSION
The developed 225Ac separation is a waste-free process which can be used to obtain pure 225Ac in a nuclear reactor.
Collapse